A股異動 | 新綸科技漲6.76% 與銀川市國資委排他協議延長1個月
格隆匯12月20日丨新綸科技(002341.SZ)漲6.76%,報6元,總市值69億元。新綸科技12月17日晚間發佈公告,公司收到《排他期延長的函》,銀川經濟技術開發區管理委員會、銀川市國資委目前已經完成對公司的初步盡職調查,相關工作正在進行中,因此,根據11月12日簽署的《戰略合作協議》約定,排他期自動延長1個月。新綸科技致力於成為以新材料為本的行業綜合服務商,目前已形成電子功能材料、新型複合材料、潔淨室工程與超淨產品三大核心產業,構築起電子功能材料、鋰電池高性能封裝材料、功能性光學薄膜材料、超淨產品與清洗、淨化工程、精密模具等業務集羣,並建立了以聚綸科技為主體的高端顯示材料產學研合作平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.